Katelyn Baker
Well-Known Member
Bloomington, Minnesota - A new medical cannabis clinic is opening in Bloomington, Minn. on Monday. The MinnMed dispensary on West 84th Street is one of 8 opening across the state by July 1.
Minnesota has one of the most restrictive medical marijuana laws in the country, only allowing patients with certain ailments to be treated with pills or liquids. Starting Aug. 1, intractable pain will be added to the list of qualifying conditions, likely causing the number of patients to grow dramatically.
Minnesota has two approved providers of medical cannabis: MinnMed and LeafLine Labs. MinnMed has patient centers in Minneapolis, Rochester, Moorhead and Bloomington. LeafLine has patient centers in Eagan and St. Cloud, with clinics in St. Paul and Hibbing set to open in July.
About 90 percent of Minnesota's medical cannabis patients reported "mild to significant" benefits during the first three months of the program, according to a Minnesota Department of Health survey. Only about 20 percent of patients reported side effects — the most serious being an increase in seizures in four patients.
About 90 percent of Minnesota's medical cannabis patients reported "mild to significant" benefits during the first three months of the program, according to a Minnesota Department of Health survey. Only about 20 percent of patients reported side effects — the most serious being an increase in seizures in four patients.
The MDH survey asked medical cannabis patients to rate their level of benefit from 1 to 7, using the following scale:
No benefit — 1
Little perceived benefit — 2
Mild or moderate perceived benefit - 3 to 5
Significant benefit - 6 or 7
For most patients, the biggest problem with their care has been the cost, with 73 percent reporting the cost to be unaffordable.
The top three conditions for medical cannabis use were severe muscle spasms, seizures and cancer. Of these three conditions, cancer had the highest patient-reported benefit scores on the survey.
The MDH survey was sent to 435 patients who made their first medical cannabis purchases during the first three months of the program, a period from July 1 to September 30, 2015. Of the 435 patients, 241 completed the survey. MDH also sent a survey to the 345 health care practitioners who certified patients as eligible for medical cannabis. Of these, 94 health care practitioners completed surveys for 169. Reports of patient benefits by certifying health care practitioners were generally more modest than patients' own reports, with about 77 percent reporting a "mild to significant benefit" for their patients.
News Moderator: Katelyn Baker 420 MAGAZINE ®
Full Article: Medical Cannabis Patient Center Opens In Bloomington, Minnesota
Author: Staff
Photo Credit: None Found
Website: Fox 9
Minnesota has one of the most restrictive medical marijuana laws in the country, only allowing patients with certain ailments to be treated with pills or liquids. Starting Aug. 1, intractable pain will be added to the list of qualifying conditions, likely causing the number of patients to grow dramatically.
Minnesota has two approved providers of medical cannabis: MinnMed and LeafLine Labs. MinnMed has patient centers in Minneapolis, Rochester, Moorhead and Bloomington. LeafLine has patient centers in Eagan and St. Cloud, with clinics in St. Paul and Hibbing set to open in July.
About 90 percent of Minnesota's medical cannabis patients reported "mild to significant" benefits during the first three months of the program, according to a Minnesota Department of Health survey. Only about 20 percent of patients reported side effects — the most serious being an increase in seizures in four patients.
About 90 percent of Minnesota's medical cannabis patients reported "mild to significant" benefits during the first three months of the program, according to a Minnesota Department of Health survey. Only about 20 percent of patients reported side effects — the most serious being an increase in seizures in four patients.
The MDH survey asked medical cannabis patients to rate their level of benefit from 1 to 7, using the following scale:
No benefit — 1
Little perceived benefit — 2
Mild or moderate perceived benefit - 3 to 5
Significant benefit - 6 or 7
For most patients, the biggest problem with their care has been the cost, with 73 percent reporting the cost to be unaffordable.
The top three conditions for medical cannabis use were severe muscle spasms, seizures and cancer. Of these three conditions, cancer had the highest patient-reported benefit scores on the survey.
The MDH survey was sent to 435 patients who made their first medical cannabis purchases during the first three months of the program, a period from July 1 to September 30, 2015. Of the 435 patients, 241 completed the survey. MDH also sent a survey to the 345 health care practitioners who certified patients as eligible for medical cannabis. Of these, 94 health care practitioners completed surveys for 169. Reports of patient benefits by certifying health care practitioners were generally more modest than patients' own reports, with about 77 percent reporting a "mild to significant benefit" for their patients.
News Moderator: Katelyn Baker 420 MAGAZINE ®
Full Article: Medical Cannabis Patient Center Opens In Bloomington, Minnesota
Author: Staff
Photo Credit: None Found
Website: Fox 9
